Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
South Korea’s KOSPI Drops More Than 4%; Sell-Sidecar Triggered
M impact | EQUITY | Oct 30, 2026, 01:09 AM UTC
Way 2 VAT Reports Q3 FY26 Revenue of A$1.90 Million
M impact | EQUITY | Oct 30, 2026, 01:09 AM UTC
Vale Reports Third-Quarter Profit of $1.255 Billion, Down From $2.685 Billion
Vale reported third-quarter earnings of $1.255 billion, or $0.29 per share, compared with $2.685 billion, or $0.63 per share, a year earlier. Revenue rose 1.7%.
M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC
Monsanto gana por unanimidad primer juicio por glifosato
El fallo del Supremo de EE. UU. precedió la victoria unánime de Monsanto en el juicio, según el titular.
M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC
Bayer’s Monsanto Wins Missouri Glyphosate Case Unanimously
M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC
PAG to Acquire About 51% of Evergrande Property
PAG will acquire China Evergrande’s entire stake in Evergrande Property, becoming its new controlling shareholder.
M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC